Benzinga | May 5, 2021 07:21AM EDT

Ionis Pharmaceuticals Q1 EPS $(0.64) Misses $(0.53) Estimate, Sales $85.00M Down From $133.00M YoY

Ionis Pharmaceuticals (NASDAQ:IONS) reported quarterly losses of $(0.64) per share which missed the analyst consensus estimate of $(0.53) by 20.75 percent. This is a 82.86 percent decrease over losses of $(0.35) per share from the same period last year. The company reported $85.00 million in sales this quarter. This is a 36.09 percent decrease over sales of $133.00 million the same period last year.